miR-205-5p Promotes Hepatic Fat Accumulation as a Downstream Effector of PPARγ Signaling

Area of Science:

• Hepatology
• Molecular Biology
• Endocrinology

Background:

• Hepatic peroxisome proliferator-activated receptor gamma (PPARγ) is implicated in liver fat accumulation, particularly in leptin-deficient (ob/ob) mice.
• The precise molecular mechanisms driving PPARγ-mediated hepatic steatosis remain incompletely understood.

Purpose of the Study:

• To elucidate the role of microRNAs in PPARγ-dependent hepatic fat accumulation.
• To identify specific microRNAs regulated by PPARγ in the liver and investigate their functional consequences.

Main Methods:

• Identification and quantification of microRNA expression in various mouse models of fatty liver disease (ob/ob mice, PPARγ knockout mice).
• Treatment of HepG2 cells with fatty acids to induce steatosis, followed by miR-205-5p overexpression.
• Analysis of lipogenic and fatty acid oxidation gene expression (ACC, ACOX1, HNF4A, NRF2) and cellular lipid content.

Main Results:

• miR-205-5p was identified as a liver-enriched microRNA upregulated by PPARγ activation and in fatty liver models.
• Overexpression of miR-205-5p in HepG2 cells promoted lipogenesis (increased ACC) and inhibited fatty acid oxidation (decreased ACOX1, HNF4A, NRF2).
• Forced expression of miR-205-5p led to increased intracellular lipid accumulation in HepG2 cells.

Conclusions:

• The PPARγ-miR-205-5p signaling axis is a key driver of hepatic fat accumulation.
• miR-205-5p acts as a downstream effector of hepatic PPARγ, influencing lipid metabolism.
• miR-205-5p represents a potential biomarker and therapeutic target for nonalcoholic fatty liver disease (NAFLD).